276 related articles for article (PubMed ID: 38033156)
21. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
[TBL] [Abstract][Full Text] [Related]
22. Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
Chen Z; Wen W; Bao J; Kuhs KL; Cai Q; Long J; Shu XO; Zheng W; Guo X
BMC Med Genomics; 2019 Sep; 12(1):131. PubMed ID: 31533728
[TBL] [Abstract][Full Text] [Related]
23. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
24. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
25. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
26. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
McCann JL; Cristini A; Law EK; Lee SY; Tellier M; Carpenter MA; Beghè C; Kim JJ; Sanchez A; Jarvis MC; Stefanovska B; Temiz NA; Bergstrom EN; Salamango DJ; Brown MR; Murphy S; Alexandrov LB; Miller KM; Gromak N; Harris RS
Nat Genet; 2023 Oct; 55(10):1721-1734. PubMed ID: 37735199
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.
Siriwardena SU; Guruge TA; Bhagwat AS
J Mol Biol; 2015 Sep; 427(19):3042-55. PubMed ID: 26281709
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
Harris RS
Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
[TBL] [Abstract][Full Text] [Related]
31. Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.
Lejeune N; Poulain F; Willemart K; Blockx Z; Mathieu S; Gillet NA
J Virol; 2021 Jun; 95(13):e0241320. PubMed ID: 33853956
[TBL] [Abstract][Full Text] [Related]
32. APOBEC3B: pathological consequences of an innate immune DNA mutator.
Burns MB; Leonard B; Harris RS
Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
[TBL] [Abstract][Full Text] [Related]
33. Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer.
Radmanesh H; Spethmann T; Enßen J; Schürmann P; Bhuju S; Geffers R; Antonenkova N; Khusnutdinova E; Sadr-Nabavi A; Shandiz FH; Park-Simon TW; Hillemanns P; Christiansen H; Bogdanova N; Dörk T
Breast Cancer Res Treat; 2017 Feb; 162(1):31-37. PubMed ID: 28062980
[TBL] [Abstract][Full Text] [Related]
34. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
[TBL] [Abstract][Full Text] [Related]
36. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3A damages the cellular genome during DNA replication.
Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of APOBEC3 enzymes by single-stranded DNAs containing 2'-deoxyzebularine.
Barzak FM; Harjes S; Kvach MV; Kurup HM; Jameson GB; Filichev VV; Harjes E
Org Biomol Chem; 2019 Nov; 17(43):9435-9441. PubMed ID: 31603457
[TBL] [Abstract][Full Text] [Related]
39. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
[TBL] [Abstract][Full Text] [Related]
40. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
